SCHEMBL8366154

SCHEMBL8366154

NC(=O)C1(c2ccccc2)CCN(N2CCC(C(N)=O)(c3ccccc3)CC2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 1/20 0.56
HSD11B1 P28845 3/20 0.53
AKR1C1 Q04828 1/20 0.48
MLYCD O95822 1/20 0.48
KMT2A Q03164 3/20 0.47
TET3 O43151 1/20 0.47
FBXL19 Q6PCT2 1/20 0.47
CXXC5 Q7LFL8 1/20 0.47
TET1 Q8NFU7 1/20 0.47
KDM2B Q8NHM5 1/20 0.47
CXXC4 Q9H2H0 1/20 0.47
KDM2A Q9Y2K7 1/20 0.47
MEN1 O00255 1/20 0.47
ADRA1A P35348 2/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1B P35368 1/20 0.45
OPRM1 P35372 4/20 0.45
OPRD1 P41143 3/20 0.45
OPRK1 P41145 3/20 0.45
SLC22A1 O15245 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2722547 0.86 AKR1C1 (0.57) OPRL1HSD11B1AKR1C1MLYCDKMT2A
SCHEMBL501923 0.86 AKR1C1 (0.57) OPRL1HSD11B1AKR1C1MLYCDKMT2A
SCHEMBL8365912 0.86 HSD11B1 (0.58) OPRL1HSD11B1AKR1C1MLYCDKMT2A
SCHEMBL12227090 0.86 OPRM1 (0.61) OPRL1HSD11B1MLYCDADRA1AADRA1D
Hydrochloric Acid SCHEMBL1804765 0.84 AKR1C1 (0.55) OPRL1HSD11B1AKR1C1MLYCDKMT2A
SCHEMBL7975314 0.83 HSD11B1 (0.55) OPRL1HSD11B1KMT2ATET3FBXL19
SCHEMBL2701832 0.83 KMT2A (0.57) OPRL1HSD11B1AKR1C1MLYCDKMT2A
SCHEMBL42114 0.82 AKR1C1 (0.70) OPRL1HSD11B1AKR1C1KMT2AMEN1
SCHEMBL2184245 0.82 AKR1C1 (0.64) OPRL1HSD11B1AKR1C1KMT2AMEN1
SCHEMBL17520399 0.82 OPRM1 (0.69) OPRL1KMT2AMEN1ADRA1AADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0810991-B1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS NOVARTIS AG (CH) 1999-04-14 EP disclosed
EP-0810991-A1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS Novartis AG (CH) 1997-12-10 EP disclosed
WO-1996026183-A1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS NOVARTIS AG (CH) 1996-08-29 WO disclosed